JonRappoport February 24 2014
In court, the tide may be turning against psychiatric-drug damage.
A recent jury decision, in which Dr. Peter Breggin testified as an expert witness, highlighted the extreme danger of the drugs.
The civil case was filed on behalf of a boy diagnosed with autism, who was then dosed with antidepressants and anti-psychotic medications (Risperdal and Zyprexa).
The boy developed two conditions, called tardive dyskinesia and tardive akathisia. Dr, Breggin’s website (www.breggin.com) depicts these conditions:
“Tardive dyskinesia describes a group of persistent or permanent movement disorders caused by antipsychotic (neuroleptic) drugs including Risperdal, Zyprexa, Invega, Abilify, Geodon, Seroquel, Latuda, Fanapt and Saphris. In addition to typical tardive dyskinesia spasms and twitches of his face, eyelids, and tongue, the youngster developed a severe case of tardive akathisia involving torturous internal agitation that drove him into constant, unrelenting motion.”
Tardive dyskinesia can most definitely indicate motor brain damage. (See Breggin, Toxic Psychiatry)
In this civil suit, the Chicago jury came back with a judgment against the treating psychiatrist, Howard Segal.
The jury award was $1.5 million. (Angel v. Segal, State of Illinois, Circuit Court, Cook County. Law Division No.09L 3496)